Intron Biotechnology, Inc.
Records under this name other than the patents Intron Biotechnology, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 63 patents it holds.
Back to Intron Biotechnology, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,263,643 | Polyphenol Compounds with Modulating Neurotransmitter Release Formerly held In force · High confidence | In force | High confidence | |
| US 9,505,779 | Tacrolimus analogues, a neuroprotective composition comprising the same, an immunosuppressive composition comprising the same, a method for preparing the same, and a mutant for producing the same Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,855,253 | Pharmaceutical composition containing FK506 derivative for treating fungal infection caused by genus Cryptococcus and genus Candida and use thereof Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,226,446 | FK506 Derivative Maintaining Nerve Regeneration Activity Without Immunosuppressive Activity, and Use Thereof Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,576,060 | FK506 derivative maintaining nerve regeneration activity without immunosuppressive activity, and use thereof Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,682,333 | Composition for Inhibiting Formation of Snare Complex, Containing Myricetin Derivatives Formerly held In force · High confidence | In force | High confidence | |
| US 7,624,454 | Hand-packing instrument in the form of gloves Formerly held Term ended Term ended Sep 7, 2026 · From the USPTO record | Term ended | Term ended Sep 7, 2026 | From the USPTO record |
| US 11,324,841 | Metal oxide nanoparticle-based magnetic resonance imaging contrast agent with a central cavity Lapsed on the fee record Ended May 10, 2026 · From the USPTO record | Lapsed on the fee record | Ended May 10, 2026 | From the USPTO record |
| US 11,219,698 | Metal oxide nanoparticle-based T1-T2 dual-mode magnetic resonance imaging contrast agent Lapsed on the fee record Ended Jan 11, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jan 11, 2026 | From the USPTO record |
| US 8,066,990 | Lysin protein having broad antibacterial activity specific to bacteria Lapsed on the fee record Ended Nov 29, 2023 · From the USPTO record | Lapsed on the fee record | Ended Nov 29, 2023 | From the USPTO record |